Please login to the form below

Tyverb

This page shows the latest Tyverb news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s first-in-class breast cancer therapy wins EU licence

A number of metastatic breast cancer treatments have been rejected by the UK cost-effectiveness watchdog over the last few years, including GlaxoSmithKline's Tyverb (lapatinib) and Roche's Herceptin (trastuzumab),

Latest news

Oncology directions

For advanced breast cancer, Novartis's newly acquired breast cancer drug Tyverb (lapatinib) scores five, but there are four drugs that score three or less, including Eisai's breast cancer medicine
Novartis and GSK complete oncology and vaccines swap

Details of the asset swap were first revealed last April. Novartis claims ownership of several marketed products - including kidney cancer therapy Votrient (pazopanib) and Tyverb (lapatinib) for breast cancer - and also
England's Cancer Drugs Fund: Fixing a broken system

eribulin), GSK's Tyverb (lapatinib) and Novartis' Afinitor (everolimus)), were to be de-listed. ... GlaxoSmithKline's Tyverb (lapatinib):. treatment of advanced breast cancer. GlaxoSmithKline's Arzerra (ofatumumab):.
Pharma condemns Cancer Drugs Fund cuts

GSK. Arzerra (ofatumumab). Chronic lymphocytic leukaemia. Tyverb (lapatinib). Breast cancer. Votrient (pazopanib).
NHS names drugs to be re-evaluated for Cancer Drugs Fund

Chronic lymphocytic leukaemia. GlaxoSmithKline. Arzerra (ofatumumab) . Chronic lymphocytic leukaemia. Tyverb (lapatinib).

More from news
Approximately 3 fully matching, plus 26 partially matching documents found.

Latest appointments

GSK's oncology president joins NuCana board

During this time he has worked on major cancer products, such as Tykerb/Tyverb and Mekinist.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior External Communications Lead: £Competitive Salary

Account director: Competitive salary and bonus scheme

Account Director: £Competitive Salary

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Senior Medical Writer, MedComms Agency: Salary TBC

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Account Manager (PR): Great Benefits

Experienced medical editor: Competitive salary and bonus scheme

Account Director, Medical Education: Salary TBC

Account Manager: £Competitive Salary

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director, Healthcare Communications: Salary TBC

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Publications director: Competitive salary and bonus scheme

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Subscribe to our email news alerts

PMHub

Add my company

Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...